Atlas Trials

Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)

Clinical trial NCT01178697 · UNKNOWN

Trial details

NCT number
NCT01178697
Sponsor
Shahid Beheshti University of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Central Retinal Vein Occlusion
Start date
2010-01-01
Primary completion
2010-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.